Investor Relations

Recent Event

Q4 2019 Aptose Biosciences Inc. Earnings Conference Call

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2019

Email Alerts

Stay informed and receive company updates straight to your inbox.

Learn More

Stock Snapshot

Company Overview

Aptose Biosciences is a clinical-stage biotechnology company developing differentiated therapies to address unmet medical needs in oncology, with a particular focus on hematologic malignancies. Aptose is advancing new therapeutics focused on well validated and novel drug targets on the leading edge of cancer research. The company's pipeline includes small molecules designed for potent single agent activity and to enhance the efficacy of existing anti-cancer therapies without overlapping toxicities. Aptose Biosciences Inc. is listed on NASDAQ under the symbol APTO and on the TSX under the symbol APS.

Investor Contact Information

Company

Aptose Biosciences Inc.
12770 High Bluff Drive
Suite 120
San Diego, CA 92130
USA
T: 858.926.2730

Investor Relations

T: 647-479-9825
ir@aptose.com

Transfer Agent

Computershare Investor Services
www.Computershare.com